Skip to content

Cigna CI Market capitalization

Market capitalization at other companies

Humana logo
HumanaHUM
$20.82B-34.8%
CVS Health logo
CVS HealthCVS
$91.37B+7.0%
UnitedHealth Group logo
UnitedHealth GroupUNH
$245.61B-48.7%
Elevance Health logo
Elevance HealthELV
$64.31B-34.7%
Cencora logo
CencoraCOR
$61.11B+13.4%
Centene logo
CenteneCNC
$16.1B-46.5%

Other financials

Income statement

See full
Revenue$68.5B+4.6%
Gross profit$14.4B-15.8%
Operating income$2.4B+19.6%
Net income$1.7B+25.0%
EPS (diluted)$6.26+29.1%

Balance sheet

See full
Cash & equivalents$7.0B-15.5%
Total equity$42.2B+4.9%
Total assets$153.27B+1.7%

Cash flow

See full
Operating cash flow$1.1B-41.1%

Valuation

See full
P/E12.2×-7.1×
P/S0.3×-0.1×

Profitability

See full
Gross margin20.6%-5.2pp
Operating margin3.4%-0.1pp
Net margin2.2%+0.3pp

Returns & leverage

See full
Return on equity15%+2.8pp
Debt / equity0.0×
Current ratio0.8×0.0×

Where this comes from

Computed from the period-end share price: $70.33B.

The official record: Cigna’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cigna's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cigna's market capitalization?
Cigna (CI) reported market capitalization of $70.33B in Q1 2026.
How has Cigna's market capitalization changed year-over-year?
Cigna's market capitalization decreased by 21.1% year-over-year, from $89.19B to $70.33B.
What is the long-term trend for Cigna's market capitalization?
Over 4 years (2021 to 2025), Cigna's market capitalization has grown at a 1.9% compound annual growth rate (CAGR), from $301.14B to $324.3B.
What does market capitalization mean?
What the stock market says the company's equity is worth.
How do you interpret market capitalization?
A size and market-sentiment gauge, not a quality measure — interpret through valuation ratios (P/E, P/S) that relate it to fundamentals.
How does market capitalization compare across companies?
Comparable across companies as a size class; the input to every equity-price valuation multiple.